These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22118560)

  • 1. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.
    de Vries JI; van Pampus MG; Hague WM; Bezemer PD; Joosten JH;
    J Thromb Haemost; 2012 Jan; 10(1):64-72. PubMed ID: 22118560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does low-molecular-weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early-onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results.
    Abheiden C; Van Hoorn ME; Hague WM; Kostense PJ; van Pampus MG; de Vries J
    BJOG; 2016 Apr; 123(5):797-805. PubMed ID: 26036190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
    Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
    Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT: a rebuttal.
    Bujold E; Gouin K; Côté S
    J Thromb Haemost; 2012 Jun; 10(6):1195; author reply 1196. PubMed ID: 22452781
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
    Areia AL; Fonseca E; Areia M; Moura P
    Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
    Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
    Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
    Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
    Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
    Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
    Chen J; Huai J; Yang H
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-pregnancy aspirin resistance appears not to be related with recurrent hypertensive disorders of pregnancy.
    Abheiden CNH; Fuijkschot WW; Arduç A; van Diemen JJK; Harmsze AM; de Boer MA; Thijs A; de Vries JIP
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():139-143. PubMed ID: 28033561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation.
    Karadağ C; Akar B; Gönenç G; Aslancan R; Yılmaz N; Çalışkan E
    J Matern Fetal Neonatal Med; 2020 Jun; 33(11):1934-1939. PubMed ID: 31550962
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
    Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI
    Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis.
    Akinshina S; Makatsariya A; Bitsadze V; Khizroeva J; Khamani N
    J Perinat Med; 2018 Oct; 46(8):893-899. PubMed ID: 29949514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
    de Jong PG; Quenby S; Bloemenkamp KW; Braams-Lisman BA; de Bruin JP; Coomarasamy A; David M; DeSancho MT; van der Heijden OW; Hoek A; Hutten BA; Jochmans K; Koks CA; Kuchenbecker WK; Mol BW; Torrance HL; Scheepers HC; Stephenson MD; Verhoeve HR; Visser J; de Vries JI; Goddijn M; Middeldorp S
    Trials; 2015 May; 16():208. PubMed ID: 25947329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.
    Groom KM; McCowan LM; Stone PR; Chamley LC; McLintock C;
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):367. PubMed ID: 27876004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
    Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.